Reducing carbapenem prescribing in high-use settings: it is possible, and it is good to talk

Intern Emerg Med. 2018 Dec;13(8):1179-1180. doi: 10.1007/s11739-018-1959-y. Epub 2018 Oct 6.

Author

Nicola Jane Fawcett^{1

2}

Affiliations

¹ Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Headley Way, Oxford, OX3 9DU, UK. Nicola.fawcett@ndm.ox.ac.uk.
² Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK. Nicola.fawcett@ndm.ox.ac.uk.

PMID: 30293174
DOI: 10.1007/s11739-018-1959-y

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents*
Antimicrobial Stewardship
Carbapenems*
Hospitals
Humans

Substances

Anti-Bacterial Agents
Carbapenems

Grants and funding

MR/M003736/1/Medical Research Council/United Kingdom